G&RT Genetical and Retinal Treatment

LB13384BUndetermined Publication Date: 2026-08-06DR MADAH NAQSHBANDI
0 Cites 0 Cited by

Patent Information

Application Number
LB13384
Authority / Receiving Office
LB · LB
Patent Type
Patents
Current Assignee / Owner
Filing Date
2025-09-01
Publication Date
2026-08-06
Estimated Expiration
2045-09-01
Patent Text Reader

Abstract

Blood lymph extracted from marine and / or river crabs supports the body's immunity and enhances its ability to fight certain intractable diseases such as iron overload and high blood pressure. Copper in the blood, thalassemia, and sclerosis Multiple sclerosis (MS) can be administered orally or by injection. Depending on the case, it also treats some genetic diseases and those resulting from aging. Retinitis pigmentosa, in particular Degeneration, (RETININIYIS PIGMENTOSA) Age-related macular degeneration Through injection, (MOCULAR DEGENERATION) With a diameter of 0.06 cc, according to the needle capacity 30 (NEEDLE GAUGE 30) It is injected directly into the vitreous body of the eye.
Need to check novelty before this filing date? Find Prior Art